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Precursor-Directed Biosynthesis: Biochemical Basis
of the Remarkable Selectivity of the Erythromycin
Polyketide Synthase toward Unsaturated Triketides
the acyl carrier protein (ACP) domain by a dedicated
acyl transferase (AT) domain. The extent of modification
of the resultant -keto acylthioester is controlled by the
specific combination of keto reductase (KR), dehydrase
(DH), and enoyl reductase (ER) domains within each
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AT and ACP loading domains that are responsible for2 Departments of Chemical Engineering,
Chemistry, and Biochemistry priming the keto synthase domain of module 1 with
propionyl-CoA [5], while a unique thioesterase (TE) do-Stanford University
Stanford, California 94305 main at the C terminus of module 6 is responsible for
the release of the mature heptaketide product and for-
mation of the 14-membered lactone of 6-dEB. In DEBS,
pairs of modules are covalently linked to form three large
polypeptides, designated DEBS1, DEBS2, and DEBS3,Summary
each of which has a subunit Mr 330,000 Da and is
active only as the corresponding homodimer [6–8].The structural basis for the striking stereochemical
Precursor-directed biosynthesis is a promising ap-discrimination among triketide analogs has been in-
proach to generating novel analogs of erythromycin andvestigated by incubating a series of N-acetyl cyste-
other polyketides [9–11]. This technique is based on theamine (-SNAC) esters of unsaturated triketides with
use of a modular polyketide synthase mutant in whichDEBS module 2TE. The triketide analogs were first
one or more of the early-stage enzyme activities havescreened under a standard set of short-term incuba-
been eliminated by inactivation or deletion of the corre-tion conditions in the presence of the extender sub-
sponding PKS domain. The resultant mutant is thusstrate methylmalonyl-CoA and NADPH. For those trike-
blocked in the biosynthesis of the natural polyketidetide analogs that served as substrates for module 2TE,
product. Formation of this natural polyketide can bethe relative specificity, represented by the kcat/KM val-
restored, however, by introduction of a synthetic deriva-ues, was quantitated. Triketide diastereomers that
tive of a natural biosynthetic intermediate, usually inwere converted in precursor-directed biosynthesis ex-
the form of the N-acetyl cysteamine (SNAC) thioester.periments to unsaturated 16-membered ring macro-
Furthermore, by using analogs of natural intermediates,lides by DEBS(KS1) were good to excellent substrates
it has been possible to utilize mutant polyketide syn-for DEBS module 2TE, whereas analogs that were
thases to generate a range of structural variants of theconverted to the 14-membered ring analogs of 10,11-
natural product itself. The three main requirements fordehydro-6-deoxyerythronolide B by DEBS(KS1) were
successful precursor-directed biosynthesis are (1) thenot turned over at all by module 2TE.
analog to be introduced, whether by feeding to intact
cells or by incubation with the mutant polyketide syn-
Introduction thase, must be chemically stable under the conditions
used; (2) the analog must be taken up and processed by
The most extensively characterized modular polyketide a PKS domain downstream of the site of the mutation;
synthase is the 6-deoxyerythronolide B synthase (DEBS) and (3) the intermediates generated by the processing of
of Saccharopolyspora erythraea, the producer of the the substrate analog must themselves be accepted and
broad-spectrum antibiotic erythromycin A [1–4]. DEBS processed by the remaining downstream PKS domains.
catalyzes the formation of the erythromycin macrolide DEBS(KS1) is a mutant of DEBS that has been inacti-
aglycone, 6-deoxyerythronolide B (6-dEB, 1), from a pro- vated by site-directed mutagenesis of the -ketoacyl-
pionyl-CoA primer and six methylmalonyl-CoA extender ACP synthase domain of module 1 (KS1). Because the
units (Figure 1). Each of the six rounds of polyketide KS1 domain would normally catalyze the first condensa-
chain condensation and functional group modification is tion step of 6-deoxyerythronolide B biosynthesis, the
mediated by a dedicated group of active sites organized DEBS(KS10) mutant is incapable of carrying out the first
into a functional unit known as a module. Each polyfunc- round of polyketide chain elongation and is thus unable
tional protein module is in turn made up of a set of to catalyze the formation of the macrolide 6-dEB (1). We
catalytic domains of 100–400 amino acids each that have described precursor-directed biosynthesis experi-
are similar in both function and sequence to individual ments in which a series of unsaturated triketides were
enzymes of fatty-acid biosynthesis. Within each module, tested as substrates for DEBS(KS1) [9, 12, 13]. The
a keto synthase (-keto acyl—acyl carrier protein syn- unsaturated triketides were designed as stable analogs
thase, KS) domain is responsible for the key chain-build- of the natural triketide product of DEBS module 2, the
ing step, involving a decarboxylative condensation of covalently bound 2,4-dimethyl-3,5-dihydroxy triketide
methylmalonyl-ACP with the growing polyketide acyl acyl-ACP intermediate, which normally serves as the
chain. The methylmalonyl moiety is itself loaded onto substrate for the ketosynthase domain of DEBS module
3. The enzyme-free N-acetyl cysteamine thioester of
this acyclic substrate undergoes rapid, non-enzyme-3 Correspondence: david_cane@brown.edu
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Figure 1. Organization of the Modular PKS, 6-Deoxyerythronolide B Synthase (DEBS)
Each DEBS protein consists of two modules, each of which is made up of a core set of -ketoacyl-ACP synthase (KS), acyltransferase (AT),
and acyl carrier protein (ACP) domains, plus additional -ketoreductase (KR), dehdyratase (DH) and enoylreductase (ER) domains, as required
for each round of polyketide chain extension by methyl malonyl-CoA- and NADPH-dependent functional-group modification. At the N terminus
of DEBS1 is a loading didomain responsible for priming module 1 with the starter propionyl-CoA and at the C terminus of DEBS3 is a
thioesterase (TE) domain that releases the mature heptaketide and catalyzes the formation of the 6-deoxyerythronolide B. Short, complementary
peptide sequences at the C and N termini, respectively, of the module 2/module 3 and module 4/module 5 pairs mediate specific protein-
protein interactions and facilitate the intermodular transfer of polyketide chain elongation intermediates to the correct downstream module
[14, 15, 27].
catalyzed lactonization even at neutral pH, precluding Relative yields from feeding experiments can provide
at best only a qualitative, and even sometimes mis-its direct use as a protein-free substrate. When the syn-
thetic triketide 2, which has a stringent geometric im- leading, estimate of the relative efficiency with which
different PKS substrates are processed. To understandpediment to cyclization, was administered to cultures
of Streptomyces coelicolor CH999/pJRJ2, the strain har- rigorously the biochemical basis for the apparent differ-
ential selectivity of the DEBS polyketide synthase forboring DEBS(KS1), the predicted unsaturated 14-mem-
bered lactone, 10,11-anhydro-6-dEB (3), was formed, as unsaturated triketide analogs, it is essential to carry out
experiments at the cell-free level in order to obtain aa result of uptake and processing of 2 by DEBS module
3 ([12]; Figure 2). Unexpectedly, however, feeding of the quantitative measure of the relative kcat/KM values for
each substrate analog. Fortunately, it is not necessarycorresponding (4S)-4-methyl triketide diastereomer 4a
to the same engineered strain of S. coelicolor gave none to work with the entire DEBS multienzyme system in
such studies. Instead, it is now possible to investigateof the corresponding C-12 epimer of 3, but instead led
to production of the derived 16-membered unsaturated the specificity of individual DEBS modules. We have
recently expressed and purified from Escherichia colimacrolactone 5a [9] (Figure 2). Similarly, administration
of the chain-shortened (4S)-4-methyl triketide 4b, as well DEBS modules 2, 3, 5, and 6, each with the natural DEBS
thioesterase (TE) domain fused downstream of the re-as the 4-desmethyl unsaturated triketides 4c and 4d, to
S. coelicolor CH999/pJRJ2 resulted in the formation of spective ACP domain so as to facilitate release of poly-
ketide products produced by each module [14]. Incuba-the corresponding 16-membered unsaturated macro-
lactones 5b–5d [13] (Figure 2). The latter results were tion of (2S, 3R)-2-methyl-3-hydroxypentanoyl-SNAC
diketide 6 with modules 2, 5, or 6TE in the presencestartling and indicated that the unsaturated triketides
4a–4d had all been selectively recognized and pro- of methylmalonyl-CoA and NADPH resulted in formation
of the triketide lactone 7, whereas incubation of 6 withcessed by DEBS module 2 rather than DEBS module 3,
as if each were a diketide analog. module 3TE gave rise to the triketide ketolactone 8 (Fig-
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Figure 2. Precursor-Directed Biosynthesis of 14-Membered and
16-Membered Macrolides
Unsaturated triketide-SNAC (N-acetyl cysteaminine) thioesters were Figure 4. Synthesis of Unsaturated Triketide Analogs
fed to a culture of S. coelicolor CH999 harboring a plasmid encoding For experimental details see reference [13]. Conditions were as
DEBS(KS1), a 6-deoxyerythronolide B synthase mutant that has follows: (A) (carboxyethylidene)triphenylphosphorane or (carboxy-
been inactivated by site-directed mutagenesis of the KS1 domain. methylene)triphenyl-phosphorane, THF, reflux, 12–24 hr. (B) K2CO3,
The 16-membered macrolides 5a–5d are isolated as the correspond- 3:1 MeOH/H2O, reflux, 3-6 hr. (C) (1) (PhO)2PON3, Et3N, DMF, 0C,
ing 5,9-hemiketals [13]. 2 hr; (2) N-acetylcysteamine. (D) HF (48% aqueous solution), 5:1
acetonitrile/H2O, room temperature, 2 hr.
ure 3). We have also compared the intrinsic substrate
specificity of each these recombinant modules for the largely but not exclusively because of significant de-
natural (2S, 3R)-2-methyl-3-hydroxypentanoyl-SNAC dike- creases in the KM for each substrate, emphasizing thetide 6 and its three diastereomers [15, 16]. In all cases, the critical role played by protein-protein interactions in de-
syn-diketide 6 was preferred over its enantiomer by a livering polyketide chain elongation intermediates to the
ratio of from 15:1 to 100:1, depending on the specific cognate elongation modules [17]. Interestingly, even the
module, as measured by relative kcat/KM values. Notably, anti-diketide-ACP thioesters were turned over by each
neither of the anti-diketide-SNAC derivatives, for exam- recombinant DEBS module, albeit at substantially reduced
ple 9, was converted to detectable quantities of the rates. We now report the results of investigating the sub-
corresponding triketide lactone 10. More recently we strate specificity of module 2TE toward a series of unsat-
have found that the corresponding diketide-ACP thioes- urated triketide-SNAC analogs and their 5-deoxy deriva-
ters are substantially better substrates for each module, tives. Several of these triketides are not processed into
full-length macrolactones by DEBS(KS1).
Results
Preparation of Unsaturated Triketide Analogs
and Tetraketide Products
The unsaturated triketides 2 and 4a–4f were each pre-
pared as previously described [9, 12, 13], with the key
step being the reaction of the corresponding protected
aldehyde with the appropriate Wittig reagent, (carboxy-
ethylidene)triphenylphosphorane or (carboxymethylene)-
triphenyl-phosphorane (Figures 4A and 4B). Triketides 11
and 12, which are the enantiomers of the known trike-
tides 2 and 4a, were prepared from the appropriate
-hydroxyaldehyde enantiomers by a minor variation of
the methodology previously described [13] (Figures 4C
and 4D). The diastereomeric purity of 2, 4a, 11, and
Figure 3. Incubation of NAC Thioesters of the Diketides 6 and 9 12 was verified by chiral HPLC analysis. Each of the
with Individual Recombinant DEBS Modules Expressed and Purified
unsaturated 5-deoxy esters 13 and 14a–14c was synthe-from E. coli
sized from the corresponding 2-methyl or straight chain
Each module mediates a single round of chain extension, and the
aliphatic aldehyde and (carboxyethylidene)triphenyl-appended TE domain catalyzes the formation of the derived triketide
phosphorane (Figure 5).lactone 6 or triketide ketolactone 8. The anti-diketide-SNAC diaste-
reomer 9 is not processed by any of the DEBS modules. For confirmation of the structures of enzymatic-reac-
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Figure 5. Synthesis of 5-Deoxy-Unsaturated Triketide Analogs
For experimental details see the Experimental Procedures section.
Conditions were as follows: (A) (carboxyethylidene)triphenylphos-
phorane, THF, reflux, 12 hr. (B) K2CO3, 3:1 MeOH/H2O, reflux, 3–6
hr. (C) (1) (PhO)2PON3, Et3N, DMF, 0C, 2 hr; (2) N-acetylcysteamine.
tion products, we also required authentic samples of
the methyl esters of each of the prospective products
of incubation of the individual triketide substrates with
module 2TE. Each of the requisite reference products
was prepared from the appropriate unsaturated carbox-
ylic acid that had already been prepared for the synthe-
sis of the corresponding -SNAC esters (Figure 6). In
each case, reduction with diisobutylaluminum hydride
followed by pyridinium dichromate oxidation gave the
unsaturated aldehyde, which was subjected to chiral Figure 7. Conversion of Unsaturated Triketides to (2R,3S)-2-
aldol reaction with the Evans reagent, (4R)-N-propionyl- Methyl-3-Hydroxy-Tetraketide Methyl Esters by Incubation with
Module 2TE, Methylmalonyl-CoA, and NADPH4-benzyloxazolidinone [18]. Hydrolysis [19], deprotec-
For experimental details see the Experimental Procedures section.tion as needed, and treatment with TMS-diazomethane
Neither 2 nor 12 are turned over by module 2TE, even upon pro-gave the desired (2R,3S)-2-methyl-3-hydroxy methyl es-
longed incubation.ters 15–17.
Incubation with DEBS Module cluding the use of 2 mM -SNAC ester, 0.2 mM DL-
[2-methyl-14C]methylmalonyl-CoA, 1 mM NADPH, and 12TE—Relative Productivity
As the first step in evaluating the effectiveness of each M purified module 2TE for 2 hr at 30C (Figure 7). In
order to avoid errors due to substrate depletion, weunsaturated -SNAC derivative as a substrate for DEBS
module 2TE, we determined the relative productivity adjusted the reaction conditions so that no more than
1% of any triketide substrate would be converted tofor conversion of each substrate by carrying out a series
of incubations under a standard set of conditions, in- tetraketide during the 2 hr incubation period. To facilitate
Figure 6. Synthesis of (2R,3S)-2-Methyl-3-
Hydroxy-Tetraketide Methyl Esters
For experimental details see the Experimen-
tal Procedures section. Conditions were as
follows: (A) DIBAL, CH2Cl2, 0C, 2 hr. (B) PDC,
CH2Cl2, room temperature, overnight. (C) (1)
(4R)-3-Propionyl-4-Benzyl-2-Oxazolidinone,
Bu2BOTf, iPr2EtN, CH2Cl2, 0C, 0.5 hr, then
78C, 0.5 hr; (2) add aldehyde,78C, 0.5 hr.
(D) H2O2, LiOH, 4:1 THF:H2O, room tempera-
ture, 12 hr. (E) 6 M HCl, 0C. (F) TMSCHN2,
1:1 benzene:MeOH, room temperature, 0.5 hr.
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Figure 8. Phosphoimaging of Radioactive
Products of the Incubation of Unsaturated
Triketide Analogs with DEBS Module 2TE
Each substrate (2 mM) was incubated with
module 2TE plus DL-[2-methyl-14C]methyl-
malonyl-CoA and NADPH as described in the
Experimental Procedures. The ethyl acetate-
soluble products were methylated with TMS-
diazomethane, and the entire mixture was
subjected to silica gel TLC developed with 4:1
EtOAc/hexane. The products were analyzed by
phosphoimaging. In the control incubation the
triketide substrate was omitted. The less-polar
band visible in each lane is dimethyl methylma-
lonate. Lanes 4a –12 were run with a separate
batch of enzyme, and the results in Figure 9
have been normalized to adjust for differ-
ences in the absolute yield of 4a.
separation and analysis of the enzymatic incubation prod- pected tetraketide 15a with a productivity comparable
to that for the processing of 6, the -SNAC analog of theucts, we converted the resulting 2-methyl-3-hydroxy car-
boxylic acids to the corresponding methyl esters by natural diketide substrate. By contrast, the syn-(4R,5R)-
triketide 2 was not a substrate for module 2TE andtreatment of the crude extract with trimethylsilyldiazo-
methane. The identities of the individual tetraketide produced no detectable tetraketide product 18 even
after prolonged incubation. Interestingly, the diastereo-products were verified by comigration on SiO2 TLC with
samples of the synthetic methyl esters, and the yields meric syn-(4S,5S)-triketide 11 was turned over with a
productivity approximately 60% that of 4a, whereas theof each were quantitated by phosphoimaging (Figure 8).
The structure of the tetraketide 15a produced by the corresponding anti-(4R,5S)-triketide 12 was not a sub-
strate for the module 2TE-catalyzed reaction andaction of module 2TE on triketide 4a was further con-
firmed by feeding 4a to a culture of S. coelicolor CH999 yielded none of the tetraketide 19. As expected, the
6-desmethyl, 4-desmethyl, and 4,6-bis(desmethyl) ana-harboring DEBS1(KS1)TE, a mutant of the DEBS1TE
ion in which KS1 has been inactivated [20], and methylat- logs 4b–4d of the anti-(4S,5R)-triketide 4a, each of which
had each been converted by cultures of S. coelicoloring the resulting product. (Data not shown.) The isolated
tetraketide methyl ester was identical to synthetic 15a harboring DEBS(KS1) to the corresponding 16-mem-
bered lactones [13], were themselves converted to theby direct NMR comparison. To calibrate the activity of
the protein preparations, we also incubated module predicted tetraketides 15b, 15c, and 15d, respectively,
by module 2TE, with relative productivities ranging2TE with 2 mM (2S,3R)-2-methyl-3-hydroxy diketide
6 under conditions identical to those used with each from 33% to 70% that exhibited by 4a. The two 2-des-
methyl triketides 4e and 4f, which were turned over withtriketide analog.
As illustrated in Figures 7 and 9, the anti-(4S,5R)- approximately one-sixth the efficiency of triketide 4a,
were also substrates for module 2TE. Finally, the un-triketide 4a was converted by module 2TE to the ex-
Figure 9. Relative Yields of 2-Methyl-3-
Hydroxy Tetraketides
Relative yields of 2-methyl-3-hydroxy tetrake-
tides resulting from the incubation of unsatu-
rated triketide analogs with DEBS module
2TE plus DL-[2-methyl-14C]methylmalonyl-
CoA and NADPH, as described in the Experi-
mental Procedures.
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Figure 10. Relative kcat/KM Values of Sub-
strate Pairs
Relative kcat/KM values determined by com-
petitive incubation of pairs of substrates with
DEBS module 2TE plus DL-[2-methyl-
14C]methylmalonyl-CoA and NADPH, and
measurement of the relative rates of product
formation, as described in the Experimental
Procedures. 4a–4c and 11 were each coincu-
bated with the deoxy analog 13 while 13 and
14a were each incubated in competition with
the diketide 6. The relative kcat/KM values were
all normalized, with that of 4a set as 100%.
saturated -SNAC esters, 13 and 14a–14c, each of which whereas the 5-deoxy triketides 13 and 14a were some-
what poorer. The triketides 4a–4c and 11 showed rela-can be thought of as a 5-deoxy triketide analog, were
all processed with efficiencies 25%–67% that of the tively minor differences in kcat, all about 30%–40% that
of the diketide 6, with most of the observed variationsstandard 4a.
in kcat/KM apparently due to changes in KM.
Substrate Specificity of DEBS Module
2TE—Competition Experiments Discussion
In order to obtain a more accurate measure of the rela-
tive substrate specificity of module 2TE toward differ- Screening of the relative productivity of module 2TE
for the four diastereomers of the unsaturated triketideent triketide analogs, we carried out competition experi-
ments in which pairs of analogs were coincubated with 4a as well as a series of desmethyl analogs of 4a con-
firmed and extended the results of the previous in vivomodule 2TE plus [14C]methylmalonyl-CoA and NADPH.
By monitoring the relative rates of formation of the de- incorporation experiments that had been carried out with
S. coelicolor CH999/pJRJ2 harboring the DEBS(KS1) mu-rived pairs of tetraketide products by TLC-phospho-
imaging, we could calculate the relative kcat/KM for each tant [9, 12, 13]. Thus, the anti-(4S,5R)-triketide 4a was
converted by module 2TE to the expected (2R,3S)-2-pair. Substrate pairs were chosen such that the two
resulting products were well resolved on TLC. Thus each methyl-3-hydroxy unsaturated tetraketide 15a in a rela-
tive yield comparable under the assay conditions to thatof the four unsaturated triketides 4a–4c and 11 were
coincubated with the deoxy analog 13, while the two of triketide 7 from the natural diketide substrate 6. The
relative kcat/KM for triketide 4a was actually 25%–50%deoxy analogs 13 and its enantiomer 14a were each
incubated in competition with the diketide 6. The nor- higher than that of natural diketide 6. By contrast, the
unsaturated syn-(4R,5R)-triketide 2 was not a substratemalized results are illustrated in Figure 10.
Interestingly, in these experiments the anti-(4S,5R)- at all for module 2, consistent with the exclusive forma-
tion of the 10,11-dehydro-6-dEB (3) from the syn-trike-triketide 4a actually displayed a relative kcat/KM 1.5 times
that of the natural syn-diketide substrate 6. The two tide 2 [12], evidently because of exclusive turnover by
the downstream DEBS module 3, which ordinarily pro-desmethyl triketides 4b and 4c exhibited relative kcat/KM
values that were 55% and 19%, respectively, that of 4a cesses (saturated) diketide substrates generated by
module 2. Unexpectedly, module 2TE also processed(82% and 29% that of the natural diketide 6). The syn-
triketide diastereomer 11 showed a comparable kcat/KM the unsaturated syn-triketide 11, the enantiomer of 2,
although the corresponding anti-triketide 12, the enanti-relative to 4a of 21%. The enantiomeric 5-deoxy unsatu-
rated triketides 13 and 14a were also efficient sub- omer of 4a, was not a substrate for module 2. These
results suggest that the configuration of the 4S-methylstrates, in spite of the absence of any hydroxyl moiety,
with relative kcat/KM values of 39% and 19%, respectively, substituent is more important in the recognition and
processing of the unsaturated triketide by module 2 thancompared to 4a (58% and 29% compared to 6).
is the configuration of the 5-hydroxyl moiety. Interest-
ingly, DEBS module 2 normally processes the (2S,3R)-Steady-State Kinetic Parameters
As a complement to the competition experiments, we 2-methyl-3-hydroxy diketide; it prefers this syn-diaste-
reomer of the -SNAC ester by a factor of 100:1 overalso directly determined the intrinsic kcat/KM values for
module 2TE of the six unsaturated triketides 4a–4c, the enantiomeric syn-diketide and completely excludes
both of the anti-diketides.11, 13, and 14a, as well as the natural diketide 6, by
carrying out steady-state kinetic measurements on each Also consistent with the previously reported precur-
sor-directed biosynthesis experiments with S. coelicolorsubstrate. (Table 1) The values obtained essentially mir-
rored the relative kcat/KM specificities determined in the [13] was the processing by module 2TE of the 6-des-
methyl analog 4b, the 4-desmethyl analog 4c, and thecompetition experiments, although the 4-desmethyl
triketide 4c appeared to be a somewhat better substrate, 4,6-bis-desmethyl analog 4d. The turnover of 4c and 4d
Specificity of Module 2TE for Unsaturated Triketides
137
Table 1. Steady-State Kinetic Parameters for Incubation of Unsaturated Triketides with Module 2TE
Substrate KM (mM) kcat (min1) kcat/KM (mmol1 min1) kcat/KM (rel)
6 5.0a 1.2a 0.24a 83
4a 1.7 0.50 0.29 100
4b 2.6 0.43 0.17 59
4c 1.6 0.36 0.20 69
11 7.2 0.41 0.056 19
13 5.5 0.46 0.073 25
14a 3.4 0.19 0.056 19
a The steady-state parameters previously determined for 6 for module 2TE expressed in E. coli BL21(DE3) were KM  3.2 mM, kcat  4.6
min1, kcat/KM 0.75 mmol1 min1 [15].
further confirms that the methyl group at C-4 is not among macrolides of different ring size is not known, but it
is noteworthy that the relevant PKS modules have evolvedessential for recognition by module 2. Indeed, the rela-
tive productivities and kcat/KM values of 4b–4d are all with different intrinsic substrate specificities and levels of
tolerance for structural variation.less than the kcat/KM value of 4a within a factor of 5.
Interestingly, the corresponding 2-desmethyl analogs 4e The -SNAC thioesters 13 and 14a–14c can be consid-
ered as 5-deoxy-2,3-unsaturated triketides. The factand 4f were also reasonably good substrates for module
2TE, with relative productivities and kcat/KM values all that all four analogs are turned over by module 2TE
indicates that the 5-hydroxyl moiety of 4a–4f is not essen-within a factor of 5–6 the kcat/KM value of 4a. In previous
whole-cell feeding experiments of 4e to S. coelicolor tial for recognition and processing of unsaturated triketide
substrates by this module. In a comparison of 13 withCH999/pJRJ2, by contrast, we had not detected any of
the corresponding unsaturated 16-membered lactone its structural analog 4b, the absence of the 5-hydroxyl
or any other recognizable macrolactone. It is not known
whether the absence of such products was simply a func-
tion of the reduced efficiency of turnover of 4e by module
2, discrimination against the derived 4-desmethyl tetra-
ketide product by downstream DEBS modules, or simply
an artifact of the in vivo feeding and fermentation condi-
tions. The latter results emphasize the fact that whereas
incorporation of a substrate analog in precursor-directed
biosynthesis experiments can be taken as positive evi-
dence that the analog and its derived intermediates can
be processed by the relevant PKS modules, the failure
to observe the expected products in such an experiment
cannot be used to draw conclusions about the relative
substrate specificity or tolerance of the PKS.
Although the anti-unsaturated triketide 4a is normally
never encountered by DEBS module 2 (or any other
DEBS module), it is in fact a natural intermediate of
biosynthesis of the 16-membered lactone tylactone (21),
normally generated by module 2 of the TylG gene prod-
uct, which includes the requisite DH domain ([21]; Gen-
bank accession number U78289) (Figure 11). Similarly,
the 2-desmethyl anti-triketide 4e is a presumed precur-
sor of 22, the aglycone of the mycinamicins, based on
the isolation of the corresponding unsaturated acid (4g)
from a wild-type strain of Micromonospora griseorubida
[22]. Intriguingly, all known 16-membered macrolides
that have a methyl at C-14 have the same 14S-(D) stereo-
chemistry and either a C-12,13 double bond or a derived
12,13-epoxide [23]. By contrast, 10,11-unsaturated 12-
and 14-membered macrolides with a methyl group at
C-12 or C-14, such as 10-deoxymethynolide (24) and
narbonolide (25), the precursors of methymycin and pi-
cromycin, respectively, all have the epimeric L-methyl
Figure 11. Unsaturated Triketides as Natural Intermediates in the
configuration, identical to that of the corresponding methyl Biosynthesis of Macrolides
group in the prototype macrolide aglycone, 6-dEB (1), and
Both 4a and 23 have been incorporated into the corresponding
are derived from precursors such as 23 with the syn- macrolide aglycones tylactone (21) and 10-deoxymethynolide (25),
(4S,5R)-4-methyl-5-hydroxy stereochemistry [24]. The whereas the unsaturated acid 4g has been isolated from the my-
cinamicin producer M. griseorubida.reasons for this divergence in substrate stereochemistry
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group results in no more than a 1.5- to 2.5-fold reduction process triketide 2 and the anti-triketide 4a to give the
corresponding tetraketides with equal catalytic effi-in relative kcat/KM values. Notably, module 2TE shows
only a relatively modest 2-fold preference in kcat/KM for ciency, but at relative rates that are 10% of those for
the processing of triketide 4a by module 2TE.13 over its enantiomer 14a. Interestingly, in this case, a
2.5 advantage for 13 in kcat is offset by a 40% reduction
in KM for 14a. It is possible that the two enantiomers are Significance
bound by module 2TE (presumably by the KS2 domain,
see below) in different conformations, in which the ethyl Precursor-directed biosynthesis has already proven
group of 14a occupies the binding site that interacts to be a powerful tool for the rational synthesis of struc-
with the corresponding methyl group of 13. tural analogs of erythromycin and related macrolides.
Although relative productivity measurements, based Successful exploitation of this technique, as well as
on the relative yield of products under standard incuba- of related approaches involving combinatorial biosyn-
tion conditions, are useful for determining whether or thesis methodology, requires a detailed understanding
not a given analog is actually a substrate for a given of the structural and stereochemical factors that con-
module, in the absence of information about either kcat trol substrate specificity and tolerance by target PKS
or KM values for each substrate, such experiments allow modules. The demonstration that the differential pro-
only qualitative comparisons of candidate substrates. cessing of syn- and anti-diastereomers of unsaturated
More quantitative evaluations of the relative specificity triketides by blocked mutants of DEBS is due to the
for each substrate requires determination of the relative intrinsic kinetic selectivity of DEBS module 2 for sub-
or absolute kcat/KM values, either by pairwise competition strate analogs of different structure establishes the
assays or by direct steady-state kinetic measurements, biochemical basis for the observed product distribu-
respectively. In fact, the results of both sets of experi- tion resulting from the in vivo feeding experiments with
ments for analogs 4a–4f, 13, and 14a are essentially in cells harboring the DEBS(KS1) mutant. By combining
agreement, with the exception of minor differences in this information with knowledge of specific protein-
the relative kcat/KM values obtained for the 4-desmethyl protein interactions within pairs of ACP donor domains
analog 4c and the deoxy analog 13. These analogs all and downstream KS acceptor domains, one should
have relative kcat/KM values that are less than the kcat/KM be able to optimize the rational production of polyke-
value of the parent analog 4a within a factor of 5, with tides of designed structure by chimeric PKS con-
most of the variation being due to increases in KM. Inter- structs based on a judicious choice of the proper com-
estingly, the slight (20%–50%) preference for the unsat- bination of modules, linkers, and substrate analogs.
urated triketide 4a over the natural diketide 6 apparently In particular, the generation of a library of hybrid 14-
results from the 3.2-fold KM reduction that compensates to 16-membered macrolide antibiotics may be possi-
for the 0.4-fold reduction in kcat. ble in the near future.
The relative kcat/KM values for the processing of each
substrate are a function of only those kinetic events up Experimental Procedures
to and including the first irreversible enzymatic step.
MaterialsThe observed differences in kcat/KM values for module
DL-[2-methyl-14C]Methylmalonyl-CoA (56.4 mCi/mmol) was ob-2TE of the various unsaturated triketides compared
tained from ARC. DL-MethylmalonylCoA and NADPH were obtained
to the natural diketide therefore necessarily reflect the from Sigma. (2S,3R)-2-Methyl-3-hydroxy pentanoyl N-acetylcyste-
intrinsic substrate specificity of only the ketosynthase amine (6) was synthesized as previously described [26]. All other
domain, KS2, and are insensitive to the intrinsic specific- reagents and solvents were commercially available products.
ities of any of the domains (KR2, TE) catalyzing down-
Product Analysis and Characterizationstream reactions. We have previously reported that pro-
1H and 13C nuclear magnetic resonance (NMR) spectra were re-cessing of the diketide-SNAC 6 by DEBS module 2
corded on a Bruker AM-300 NMR spectrometer. Chemical shifts areinvolves covalent acylation of the active site cysteine of
reported in ppm relative to tetramethylsilane, and J values are inKS2 [25], and we have demonstrated that this acylated
Hz. A Kratos MS80RFA Mass Spectrometer was used to obtain high-
protein is catalytically competent [2]. In addition to the resolution mass spectra (reported as m/z) by fast atom bombard-
rates of binding and dissociation of each substrate ana- ment (FAB). High-pressure liquid chromatography (HPLC) was per-
formed on a Rainin Dynamax HPLC system equipped with a Chiralcellog to the KS2 domain, the kcat/KM is a function of the
OC column (Diacel, 25 cm  4.6 mm inner diameter; guard column,rate constants for acylation and deacylation of the active
5 cm  4.6 mm inner diameter); a mobile phase of 10% of ethanolsite cysteine, as well as the irreversible decarboxylative
in hexane at a flow rate of 1 ml/min was used. The elution wascondensation with methymalonyl-ACP2. Of course,
monitored by UV at 232 nm. Enzymatically generated products were
should the original acylation also be irreversible, then separated on silica gel TLC plates, and the radioactivity of individual
only the acylation step would influence kcat/KM. We are components was quantitated by phosphoimaging with a Bio-Rad
currently examining the relative contribution of KS-cata- GS-363 Molecular Imager and Molecular Analyst software; stan-
dards of known radioactivity were used.lyzed acylation and condensation to substrate discrimi-
nation. In spite of the remarkably broad substrate toler-
Isolation and Purification of DEBS Module 2TEance of module 2, this module strictly excludes both
The DEBS module 2TE was expressed and purified by a variationunsaturated triketides 2 and 12. The fact that, nonethe-
of the previously published method [14, 15]. E. coli BL21-Codon-less, DEBS(KS1) will convert 2 to 10,11-dehydro-6dEb
Plus(DE3)-RP (Stratagene) harbors plasmid pRSG64, which encodes
(3) indicates that the latter triketide diastereomer must module 2TE, and a plasmid containing the sfp phosphopantethei-
be a viable substrate for module 3. Indeed, we have nyl transferase gene from Bacillus subtilis [14]. The Sfp protein is
essential for the activity of module 2TE because it catalyzes post-now found that recombinant module 3TE can in fact
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translational phosphopantetheinylation of the apo-ACP2 domain. A Chromatography (150 g silica, 40% EtOAc/hexane) afforded 7.8 g
(100%) of (4R)-4-benzyl-3-butyryl-2-oxazolidinone as a colorless oil;500-ml culture was grown at 37C in LB medium supplemented with
ampicillin, kanamycin, and chloamphenicol until OD600  0.6. After 1H NMR (300 MHz, CDCl3): 	 1.04 (t, J  7.37, 3H, 4
-H), 1.75 (m,
2H, 3
-H), 2.78 (dd, J  9.64 and 13.4, 1H, 6b-H), 2.95 (m, 2H, 2
-H),cooling to 26C–28C, the cells were induced with 1 mM IPTG and
incubated at this temperature for 10 hr (final OD600  2.5). The har- 3.32 (dd, J  3.29 and 13.4, 1H, 6a-H), 4.20 (m, 2H, 5-H), 4.69 (m,
1H, 4-H), 7.22–7.38 (m, 5H, Ph). To 7.8 g, (31.1 mmol) of this imidevested cells were disrupted with a French Press (1000 psi) in the
previously described disruption buffer [14, 15], and the resulting in THF (50 ml) at 78C was added NaHMDS (35 ml of 1 M solution
in THF, 34.3 mmol) via syringe. The mixture was stirred for 30 min,supernatant was treated with DNase (20 g/ml, 10 mM MgCl2) for
20 min, followed by precipitation with 0.15% polyethylenimine (PEI) and methyl iodide (11 g, 77.8 mmol) was added. After 2 hr, the
reaction was quenched with 30 ml of saturated NaCl solution. Thefor 20 min. After ultracentrifugation, the cell-free extract was diluted
twice by buffer A (0.1 M sodium phosphate buffer [pH 7.2], 20% THF was evaporated, and the mixture was extracted with 3  50
ml of CH2Cl2. Drying (Na2SO4), concentration, and silica gel chroma-glycerol) and then directly loaded on Q Sepharose (Amersham Phar-
macia Biotech AB) gel. The module 2TE protein was eluted with tography (200 g silica gel, 20% ether/pentane) afforded 5.5 g (67%)
of (4R,2
R)-4-benzyl-3-(2
-methylbutyryl)-2-oxazolidinone as a col-a linear gradient of 0.2 M (100 ml) to 0.5 M (100 ml) NaCl, emerging
orless oil; 1H NMR (300 MHz, CDCl3): 	 0.95 (t, J  7.42, 3H, 4
-H),at approximately 0.25 M NaCl. The combined fractions containing
1.24 (d, J  6.78, 3H, 2
-CH3), 1.5 and 1.8 (m, 2H, 3
-H), 2.79 (dd,module 2TE protein were loaded on a 1 ml Ni2 affinity column
J  9.57 and 13.4, 1H, 6b-H), 3.29 (dd, J  3.28 and 13.4, 1H, 6a-(Amersham Pharmacia Biotech AB) and washed with buffer A  20
H), 3.66 (m, 1H, 2
-H), 4.20 (m, 2H, 5-H), 4.70 (m, 1H, 4-H), 7.22–7.38mM imidazole. Purified module 2 eluted with buffer A  500 mM
(m, 5H, Ph). The oxazolidinone (3.6 g, 13.9 mmol) in Et2O (50 ml)imidazole and was concentrated by Centricon 30 with buffer B (0.1
was reduced with LiAlH4 (42 ml of 1 M solution in THF, 42 mmol)M sodium phosphate buffer [pH 7.2], 20% glycerol, 2 mM EDTA,
for 1 hr at 78C, after which the reaction was quenched with suc-2.5 and mM DTT). The pure enzyme could be stored at80C without
cessive portions of 1.6 ml water, 1.6 ml 15% NaOH solution, andsignificant loss of activity over several months.
4.8 ml water. After filtration and washing with ether, the organic
phase was dried (Na2SO4) and concentrated. Chromatography (50Assays
g silica, 20% EtOAc/hexane) afforded 1.2 g (95%) of (2R)-2-methyl-Productivity assays were carried out with 1 M module 2TE pro-
1-butanol as a colorless oil; 1H NMR (300 MHz, CDCl3): 	 0.94 (d,tein, 2 mM substrate, 1 mM NADPH, 200 M DL-[2-methyl-14C]meth-
J  6.65, 3H, 2-CH3), 0.95 (t, J  7.39, 3H, 4-H), 1.2 and 1.5 (m, 3H,ylmalonyl-CoA (1 mCi/mmol), 100 mM Na-phosphate buffer (pH 7.2),
2-H, and 3-H), 3.48 (m, 2H, 1-H). (2R)-2-methyl-1-butanol (300 mg,20% glycerol, 10% DMSO (to solubilize the substrate), 2.5 mM DTT,
3.4 mmol) was stirred in CH2Cl2 (10 ml) at room temperature. PDCand 2 mM EDTA in a total volume of 100 l at 30C for 1 or 2 hr.
(3.9 g, 10.2 mmol) was added, and the mixture was stirred overnight.The incubation mixture was saturated with solid NaCl and extracted
The solution was then applied to a silica gel (20 g) column that waswith ethyl acetate. The residue after evaporation of the solvent was
eluted with CH2Cl2. After rotary evaporation (bath temperature, 0C),treated with 10 l of 2 M TMS-diazomethane in 40 l of 50% CH3OH/
the desired (2R)-2-methylbutyraldehyde was obtained; 1H NMR (300benzene at 37C for 1 hr to generate the methyl ester of the product.
MHz, CDCl3): 	 0.97 (t, J 7.43, 3H, 4-H), 1.11 (d, J 6.99, 3H, 2-CH3),The entire methylation reaction mixture was then applied to a TLC
1.45 and 1.75 (m, 2H, 3-H), 2.31 (dt, J  1.94 and 6.86, 1H, 2-H), andplate, which was developed with either 1:1 or 4:1 EtOAc/hexane
9.65 (d, J  2.0, 1H, 1-H). The aldehyde was dissolved in 30 ml ofand analyzed by phosphoimaging (Figures 8 and 9).
THF and treated with 1.7 g (4.5 mmol) of (carbethoxyethylidene)tri-For competition assays, pairs of substrates (2 mM each; total
phenylphosphorane at reflux for 12 hr. The THF was evaporated,DMSO concentration, 10%) were coincubated with the standard
and residue was subjected to silica filtration with 10% EtOAc/hexaneassay mixture for 1 hr and 2 hr, followed by extraction and methyla-
to remove triphenylphosphine oxide. Concentration gave ethyl (2E,tion as above. Over the 2 hr time period, less than 5% of each
4R)-2,4-dimethyl-2-hexenoate (130 mg, 22% from alcohol); 1H NMR
substrate was consumed. Substrate pairs were chosen so that the
(300 MHz, CDCl3): 	 0.86 (t, J  7.42, 3H, 6-H), 0.99 (d, J  6.68,derived tetraketide products were readily resolved by TLC, and the
3H, 4-CH3), 1.3 (t, J  7.14, 3H, -CH2CH3), 1.3–1.5 (m, 2H, 5-H), 1.83yields at each time point were quantitated by phosphoimaging. Each
(d, J  1.49, 3H, 2-CH3), 2.41 (m, 1H, 4-H), 4.19 (q, J  7.15, 2H,incubation was carried out in triplicate, and the results were aver-
-CH2CH3), 6.52 (dq, J  1.41.5, and 10.1, 1H, 3-H). The ethyl esteraged to calculate the relative kcat/KM values illustrated in Figure 10. (130 mg, 0.76 mmol) was dissolved in 30 ml of methanol and 10 ml
For steady-state kinetic assays, incubations were carried out for
of H2O containing 1.6 g (12 mmol) of K2CO3, and the mixture was1 hr with a range of triketide concentrations from 0.5 to 4 mM. stirred at reflux for 6 hr. The methanol was evaporated, and the
The natural diketide substrate 6 was also assayed for comparison remaining aqueous layer was acidified to pH 2 with concentrated
purposes (Table 1). HCl, saturated with NaCl, and extracted with EtOAc. The combined
organic extracts were dried over Na2SO4 and concentrated. (2E,
Substrate Synthesis 4R)-2,4-dimethyl-2-hexenoic acid (100 mg, 90%) was obtained as
Triketide-SNAC esters 2 and 4a–4f were synthesized as previously a colorless oil; 1H NMR (300 MHz, CDCl3): 	 0.86 (t, J  7.39, 3H,
described [9, 12, 13], whereas 11 (the enantiomer of 2) and 12 (the 6-H), 1.02 (d, J  6.68, 3H, 4-CH3), 1.25–1.53 (m, 2H, 5-H), 1.86 (d,
enantiomer of 4a) were each prepared by similar methods from the J  1.25, 3H, 2-CH3), 2.45 (m, 1H, 4-H), 6.71 (dd, J  1.21 and 10.1,
corresponding enantiomeric protected 3-hydroxyaldehydes, with 1H, 3-H). Under N2 atmosphere, 100 mg (0.7 mmol) of this acid was
deprotection of the 5-hydroxy group preceding formation of the dissolved in 5 ml of DMF and treated with diphenylphosphoryl azide
-SNAC ester. The enantiomeric purity of 2, 4a, 11, and 12 was verified (170 l, 0.77 mmol) and 136 l (0.84 mmol) of Et3N at 0C for 2 hr,
by HPLC with a Chiralcel OC column under the conditions described after which N-acetylcysteamine (84 mg, 0.7 mmol) was added. After
above. Retention time: 2, 40.55 min; 4a, 34.01 min; 11, 37.28 min; the mixture was stirred at room temperature for 5 hr, 10 ml of H2O
12, 38.91 min. was added, and the mixture was extracted with EtOAc. Drying over
(4R)-2,4-Dimethyl-2-Hexenoic Acid N-Acetylcysteamine Na2SO4, concentration, and flash chromatography (silica gel 20 g,
Thioester (13) 50% EtOAc/hexane) yielded 85 mg (50%) of 13 as a colorless oil;
(R)-()-4-benzyl-2-oxazolidinone (5.1 g, 28.8 mmol) was stirred in 1H NMR (300 MHz, CDCl3): 	 0.89 (t, J  7.47, 3H, 6-H), 1.04 (d, J 
the THF (50 ml) at 78C for 10 min. To the mixture, n-butyllithium 6.67, 3H, 4-CH3), 1.25–1.53 (m, 2H, 5-H), 1.91 (d, J  1.35, 3H, 2-CH3),
(12 ml of 2.5 M solution in hexane, 30 mmol) was added via syringe. 1.99 (s, 3H, C(O)CH3), 2.48 (m, 1H, 4-H), 3.08 (t, J  6.0, 2H, S-CH2),
The mixture was stirred for 10 min, and butyryl chloride (4.56 g, 42.8 3.48 (q, J  6.0, 2H, N-CH2), 5.9 (broad, 1H, NH), 6.56 (dq, J 
mmol) was added. After 10 min the cooling bath was removed, and 1.31.4 and 9.88, 1H, 3-H). 13C NMR (75.5 MHz, CDCl3): 	 12.3,
the reaction was allowed to warm to 0C over 30 min. The reaction 13.0, 19.9, 23.6, 28.8, 30.0, 35.5, 40.2, 135.0, 147.9, 170.7, 194.7;
was quenched with 20 ml of saturated NH4Cl solution at 0C. The []D 35.5 (c  1.0, CHCl3); HRMS (FAB, NBA/NaI), calculated for
THF was removed by rotary evaporation, and the mixture was ex- (C12H21NO2S)Na 266.1191, found 266.1200. The enantiomeric purity
tracted with 3  50 ml of CH2Cl2. The combined organic extract was of 13 was determined by conversion of a portion of the (4R)-2,4-
washed with 20 ml of 1 N NaOH and subsequently with 20 ml of dimethyl-2-hexenoic acid to the corresponding (4S)-4-benzyl-
2-oxazolidinone imide by treatment with oxalyl chloride and reactionbrine. The organic phase was dried with Na2SO4 and concentrated.
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of the resulting acid chloride with (4S)-4-benzyl-2-oxazolidinone. 4
-nonenoyl]-2-oxazolidinone as a colorless oil. 1H NMR (300 MHz,
CDCl3): 	 0.04 and 0.06 (s, 6H, Si(CH3)2), 0.83 (t, J  7.46, 3H, 9
-H),Measurement of the relative 1H NMR signal intensity for the (4
R)-
4
-CH3 group (	 1.01 (d, J  6.67 Hz) and that of the (4
S)- 4
-CH3 0.90 (s, 9H, SiC(CH3)3), 0.94 (d, J  6.72, 3H, 6
-CH3), 1.19 (d, J 
7.00, 3H, 2
-CH3), 1.35-1.55 (m, 2H, 8
-H), 1.63 (d, J 1.01, 3H, 4
-CH3),group (	 1.02 (d, J  6.67 Hz) of the minor 4
S –diastereomer estab-
lished the 4
R/4
S ratio to be 94:6. 2.51 (m, 1H, 6
-H), 2.79 (dd, J  9.46 and 13.4, 1H, 6b-H), 3.27 (dd,
J  3.19 and 13.4, 1H, 6a-H), 3.47 (m, 1H, 7
-H), 3.98 (m, 1H, 2
-H),(4S)-2,4-Dimethyl-2-Hexenoic Acid N-Acetylcysteamine
Thioester (14a) 4.20 (m, 2H, 5-H), 4.36 (broad, 1H, 3
-H), 4.68 (m, 1H, 4-H), 5.42 (d,
J 9.91, 1H, 5
-H), 7.2-7.4 (m, 5H, Ph). To a solution of oxazolidinone14a was prepared by the procedure described for 13 from (2S)-
(-)-2-methyl-1-butanol (Aldrich). The 1H and 13C NMR spectra were (30 mg, 0.06 mmol) in THF/H2O (5 ml, 4:1) at 0C, 30% aqueous
hydrogen peroxide (100 l), followed by LiOH•H2O (100 mg), wasidentical to those of 13. 14a: []D 34.4 (c  0.5, CHCl3); HRMS
(FAB, NBA/NaI), calculated for (C12H21NO2S)Na 266.1191, found added slowly. The mixture was stirred at room temperature for 12 hr.
The reaction was quenched with a solution of sodium sulfite (3 ml266.1198. 1H NMR analysis of the corresponding (4S,2
E,4
R)-
4-benzyl-3-(2
,4
-dimethyl-2
-hexenoyl)-2-oxazolidinone gave a of 20% aqueous solution) and stirred until peroxides were no longer
detectable (30 min). The THF was evaporated and resulting solution4
S/4
R ratio of 84:16.
was extracted with CH2Cl2. After acidification at 0C with 6 M HCl,2-Methyl-2-Pentenoic Acid N-Acetylcysteamine Thioester (14b)
the water layer was extracted with ethyl acetate. The combined ethyl14b was prepared by a procedure analogous to that used for 13.
acetate layer were concentrated, and the residue was dissolved in14b: 1H NMR (300 MHz, CDCl3): 	 1.09 (t, J  7.57, 3H, 5-H), 1.87
5% NaHCO3. After extraction with CH2Cl2 and acidification (as(d, J  1.01, 3H, 2-CH3), 2.00 (s, 3H, C(O)CH3), 2.24 (m, 2H, 4-H),
above), the water layer was extracted with ethyl acetate. During3.08 (t, J  6.1, 2H, S-CH2), 3.47 (q, J  6.0, 2H, N-CH2), 6.05 (broad,
the extraction, the TBS group was deprotected spontaneously. The1H, NH), 6.76 (tq, J  1.39 and 7.24, 1H, 3-H). 13C NMR (75.5 MHz,
combined ethyl acetate layers were dried over Na2SO4 and concen-CDCl3): 	 12.7, 13.3, 22.5, 23.6, 28.8, 40.2, 135.7, 143.9, 170.7, 194.4;
trated to yield (2R,3S,6S,7S)-3,7-dihydroxy-2,4,6-trimethyl-4-non-HRMS (FAB, NBA/NaI), calculated for (C10H17NO2NS)Na 238.0878,
enoic acid; 1H NMR (300 MHz, CDCl3): 	 0.94 (t, J  7.45, 3H, 9-H),found 238.0879.
0.99 (d, J  6.76, 3H, 6-CH3), 1.19 (d, J  6.99, 3H, 2-CH3), 1.3–1.62-Methyl-2-Hexenoic Acid N-Acetylcysteamine Thioester (14c)
(m, 2H, 8-H), 1.65 (d, J  0.83, 3H, 4-CH3), 2.53 (m, 1H, 6-H), 2.7214c was prepared by a procedure analogous to that used for 13.
(m, 1H, 2-H), 3.39 (m, 1H, 7-H), 4.28 (d, J  6.08, 1H, 3-H), 5.38 (d,14c: 1H NMR (300 MHz, CDCl3): 	 0.96 (t, J  7.39, 3H, 6-H), 1.50
J  9.86, 1H, 5-H). The carboxylic acid was dissolved in 1 ml of(tq, J  7.44, 2H, 5-H), 1.88 (d, J  1.09, 3H, 2-CH3), 2.00 (s, 3H,
50% benzene/methanol and treated with 50l of trimethylsilyldiazo-C(O)CH3), 2.21 (m, 2H, 4-H), 3.08 (t, J  6.1, 2H, S-CH2), 3.47 (q, J 
methane (2 M in hexane) for 30 min at room temperature. After6.0, 2H, N-CH2), 6.02 (broad, 1H, NH), 6.79 (tq, J  1.4 and 7.35, 1H,
concentration, chromatography (20% EtOAc/hexane) afforded 5.23-H). 13C NMR (75.5 MHz, CDCl3): 	 12.8, 14.3, 22.1, 23.6, 28.8, 31.2,
mg (two steps, 30%) of 16; 1H NMR (300 MHz, CDCl3): 	 0.95 (t, J 40.3, 136.3, 142.5, 170.8, 194.4; HRMS (FAB, NBA/NaI), calculated
7.4, 3H, 9-H), 0.99 (d, J  6.7, 3H, 6-CH3), 1.16 (d, J  7.0, 3H,for (C11H19NO2S)Na 252.1035, found 252.1027.
2-CH3), 1.2–1.6 (m, 2H, 8-H), 1.63 (d, J  1.3, 3H, 4-CH3), 2.49 (m,
1H, 6-H), 2.70 (m, 1H, 2-H), 3.31 (m, 1H, 7-H), 3.68 (s, 3H, -OCH3),Product Synthesis 4.25 (d, J  5.5, 1H, 3-H), 5.34 (dt, J  1.2 and 9.9, 1H, 5-H). 1H
Methyl (2R, 3S, 6S, 7S)-3, 7-Dihydroxy-2,4,6-Trimethyl- NMR (300 MHz, CD3OD): 	 0.92 (t, J  7.3, 3H, 9-H), 0.99 (d, J 4-Nonenoate (16) 6.7, 3H, 6-CH3), 1.18 (d, J  6.9, 3H, 2-CH3), 1.2–1.6 (m, 2H, 8-H),
Ethyl (2E,4S,5S)-5-(tert-butyldimethylsiloxy)-2,4-dimethyl-2-hepteno- 1.62 (d, J  1.3, 3H, 4-CH3), 2.37 (m, 1H, 6-H), 2.68 (m, 1H, 2-H),
ate (180 mg, 0.57 mmol) was dissolved in CH2Cl2, and treated with 3.31 (m, 1H, 7-H), 3.62 (s, 3H, -OCH3), 4.06 (d, J  7.9, 1H, 3-H),
DIBAL (1.2 ml of 1 M hexane, 1.2 mmol) at 0C. After 2 hr, the reaction 5.22 (dt, J  1.0 and 9.9, 1H, 5-H). 13C NMR (75.5 MHz, CDCl3): 	
was quenched with 2 ml of EtOAc followed by 5 ml of 1 M tartaric 10.7 (C9), 12.0 (2-CH3), 13.1 (4-CH3), 16.5 (6-CH3), 27.5 (C8), 38.4
acid. The mixture was extracted with CH2Cl2, and the organic extract (C6), 43.4 (C2), 52.2 (OCH3), 77.5 (C7), 77.6 (C3), 130.4 (C5), 134.8
was dried with MgSO4 and concentrated to yield (2E,4S,5S)-5-(tert- (C4), 176.6 (C1). 13C NMR (75.5 MHz, CD3OD): 	 9.67 (C9), 11.2
butyldimethylsiloxy)-2,4-dimethyl-2-heptenol: 1H NMR (300 MHz, (2-CH3), 12.3 (4-CH3), 16.0 (6-CH3), 27.8 (C8), 38.7 (C6), 44.3 (C2),
CDCl3): 	 0.04 (s, 6H, Si(CH3)2), 0.85 (t, J  7.5, 3H, 7-H), 0.90 (s, 9H, 51.1 (OCH3), 77.2 (C7), 78.6 (C3), 131.0 (C5), 135.0 (C4), 175.9 (C1).
SiC(CH3)3), 0.94 (d, J  6.7, 3H, 4-CH3), 1.45 (m, 2H, 6-H), 1.68 (d, HRMS (FAB, NBA/NaI) calculated for (C13H24O4)Na 267.1573, found
J  1.4, 3H, 2-CH3), 2.51 (m, 1H, 4-H), 3.44 (m, 1H, 5-H), 4.00 (s, 2H, 267.1570.
1-H), 5.28 (dd, J  1.3 and 10.1, 1H, 3-H). This product was reacted Triketide-SNAC thioesters 15a–15f and 17a–17c were prepared
with PDC (430 mg, 1.14 mmol) in 10 ml CH2Cl2 at room temperature by procedures analogous to those used to synthesize 16.
overnight. The resulting mixture was loaded on a silica gel (20 g) 15a: 1H NMR (300 MHz, CDCl3): 	 0.9–1.0 (m, 6H, 9-H and 6-CH3),
column that was eluted with CH2Cl2 to give (2E,4S,5S)-5-(tert-butyl- 1.14 (d, J  7.0, 3H, 2-CH3), 1.2–1.6 (m, 2H, 8-H), 1.65 (s, 3H, 4-CH3),
dimethylsiloxy)-2,4-dimethyl-2-heptenal (91 mg, two steps 59%); 1H 2.50 (m, 1H, 6-H), 2.72 (m, 1H, 2-H), 3.31 (m, 1H, 7-H), 4.27 (d, J 
NMR (300 MHz, CDCl3): 	 0.04 (s, 6H, Si(CH3)2), 0.88 (t, J  7.5, 3H, 6.4, 1H, 3-H), 5.35 (d, J  10, 1H, 5-H). 1H NMR (300 MHz, CD2Cl2):
7-H), 0.90 (s, 9H, SiC(CH3)3), 1.05 (d, J  6.7, 3H,4-CH3), 1.35–1.65 	 0.9–1.0 (m, 6H, 9-H and 6-CH3), 1.16 (d, J 7.1, 3H, 2-CH3), 1.2–1.6
(m, 2H, 6-H), 1.76 (d, J  1.2, 3H, 2-CH3), 2.82 (m, 1H, 4-H), 3.56 (m, (m, 2H, 8-H), 1.63 (s, 3H, 4-CH3), 2.43 (m, 1H, 6-H), 2.70 (m, 1H, 2-H),
1H, 5-H), 6.42 (dd, J  1.2 and 9.7, 1H, 3-H), 9.39 (s, 1H, H-1). 3.27 (m, 1H, 7-H), 3.66 (s, 3H, -OCH3), 4.25 (d, J  5.5, 1H, 3-H),
(4R)-3-propionyl-4-benzyl-2-oxazolidinone (78 mg, 0.33 mmol) was 5.33 (5-H). 13C NMR (75.5 MHz, CDCl3): 	 10.3 (C9), 11.9 (2-CH3), 13.0
dissolved in 10 ml of dry CH2Cl2 at 0C and treated with Bu2BOTf (4-CH3), 17.4 (6-CH3), 27.6 (C8), 38.5 (C6), 43.5 (C2), 52.3 (OCH3),
(366 l of 1 M in CH2Cl2, 0.37 mmol) and iPr2EtN (70 l, 0.4 mmol) 77.2 (C7), 77.6 (C3), 129.2 (C5), 136.3 (C4), 176.3 (C1). HRMS (FAB,
for 30 min at 0C followed by 30 min at 78C. The unsaturated NBA/NaI) calculated for (C13H24O4)Na 267.1573, found 267.1584.
aldehyde (91 mg, 0.33 mmol) was added in one portion. The reaction 15b: 1H NMR (300 MHz, CDCl3): 	 0.95 (t, J  6.73, 3H, 6-CH3),
mixture was stirred at 78C for 30 min and then allowed to warm 1.15 (d, J  6.21, 3H, 8-H), 1.17 (d, J  7.02, 3H, 2-CH3), 1.65 (d,
to room temperature over 2 hr. After cooling to 0C, the reaction J  1.1, 3H, 4-CH3), 2.37 (m, 1H, 6-H), 2.71 (m, 1H, 2-H), 3.49 (m,
was quenched by addition of 5 ml of phosphate buffer (pH 7.4), 1H, 7-H), 3.68 (s, 3H, -OCH3), 4.26 (d, J  6.15, 1H, 3-H), 5.31 (d,
poured into a 250-ml flask containing 8 ml of methanol, cooled to J  10.0, 1H, 5-H). 13C NMR (75.5 MHz, CDCl3): 	 12.3 (2-CH3), 13.0
0C, and treated with a solution of 10 ml of precooled 30% aqueous (4-CH3), 17.3 (6-CH3), 20.5 (C8), 40.8 (C6), 43.5 (C2), 52.3 (OCH3),
H2O2 for 1 hr. The organic solvents were removed by rotary evapora- 72.2 (C7), 77.6 (C3), 130.4 (C5), 136.8 (C4), 176.4 (C1). HRMS (FAB,
tion, aqueous NaHCO3 (20 ml) was added, and the resultant solution NBA/NaI) calculated for (C12H22O4)Na 253.1416, found 253.1414.
was extracted with CH2Cl2. The organic layer was treated with 20 15c: 1H NMR (300 MHz, CDCl3): 	 0.96 (t, J  7.41, 3H, 9-H), 1.16
ml of 2 M Na2SO3 for 30 min and was again extracted with CH2Cl2. (d, J  7.02, 3H, 2-CH3), 1.4–1.6 (m, 2H, 8-H), 1.63 (s, 3H, 4-CH3),
The combined extracts were dried over MgSO4 and concentrated. 2.23 (m, 1H, 6-H), 2.71 (m, 1H, 2-H), 3.60 (m, 1H, 7-H), 3.68 (s, 3H,
Flash chromatography (15 g silica, 20% EtOAc/hexane) afforded 50 mg -OCH3), 4.29 (d, J  5.53, 1H, 3-H), 5.53 (t, J  8.0, 1H, 5-H). 13C
(56%) of recovered aldehyde and 70 mg (43%) of (4R,2
R,3
S,6
S,7
S)- NMR (75.5 MHz, CDCl3): 	 10.4 (C9), 11.9 (2-CH3), 13.1 (4-CH3), 30.1
(C8), 35.6 (C6), 43.5 (C2), 52.2 (OCH3), 73.3 (C7), 77.3 (C3), 123.54-benzyl-3-[7
-(tert-butyldimethylsiloxy)-3
-hydroxy-2
,4
,6
-trimethyl-
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